Eli Lilly must shell out $61.2 million to Illinois after a jury found the Indianapolis-based pharmaceutical company made false Medicaid claims through omitting average manufacturer prices in its calculations, court documents show.
Related Posts
Becker’s 11th Annual Meeting: 4 Questions with Robert Pearl, Physician at Stanford University Medical and Business School
Channels, Featured, Leadership & Management / December 9, 2019 December 9, 2019